Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Societe Generale Initiates Coverage On UCB with Buy Rating

Societe Generale initiates coverage on UCB (OTC:UCBJY) with a Buy rating.
byBenzinga Newsdesk
July 9, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Societe Generale initiates coverage on UCB (OTC:UCBJY) with a Buy rating.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

$1.1 Million Bet On TRACON Pharmaceuticals? 4 Penny Stocks Insiders are Buying

By Lisa Levin
Today, 3:51 AM
U.S. stocks opened sharply higher on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

MIND

Read More

MaxCyte Signed Strategic Platform License with Curamys to Enable Cell & Gene Therapies for the Treatment of Rare Intractable Diseases

By Charles Gross
Today, 3:51 AM
MaxCyte, Inc., (NASDAQ:MXCT, LSE: MXCT))), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research, and Curamys, a South Korean biotechnology company that develops cell & gene therapy using cell fusion technology to treat

MXCT